Note: Ingredients listed on restricted chemical lists
EC/CAS
205-634-3/144-62-7
Name of the chemical
oxalic acid
Concentration
<=100%
General Information
Version
6.8
Revision date
2024-03-07
Product name
Oxalic acid
CAS No.
144-62-7
1.2.1 Relevant identified uses
Laboratory chemicals, Synthesis of substances
1.2.2. Uses advised against
The product is being supplied under the TSCA R&D Exemption
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H312, H318, H402
Hazard statements
Code
Statements
H302+H312
Harmful if swallowed or in contact with skin
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Signal word
Danger
Hazard statements
H302 + H312 Harmful if swallowed or in contact with skin. H318 Causes serious eye damage. H402 Harmful to aquatic life.
Precautionary statements
P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P305 + P351 + P338 + IF IN EYES: Rinse cautiously with water for several minutes. P310 Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor. P363 Wash contaminated clothing before reuse. P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
- none
2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) Acute toxicity, Oral (Category 4), H302 Acute toxicity, Dermal (Category 4), H312 Serious eye damage (Category 1), H318 Short-term (acute) aquatic hazard (Category 3), H402 For the full text of the H-Statements mentioned in this Section, see Section 16.
